by Chris Barrett | Jul 7, 2022 | Press Releases
Renovia receives FDA clearance for leva® Pelvic Health System as first-line treatment for chronic fecal incontinence Clearance for new indication follows FDA Breakthrough Device Designation BOSTON, July 7, 2022 /PRNewswire/ — Renovia Inc....
by Chris Barrett | Jun 20, 2022 | Press Releases
Abstracts at AUGS/IUGA Scientific Meeting affirm leva’s treatment value for female urinary incontinence 8 weeks of treatment with leva delivers symptom improvement for one year: real-world data establishes efficacy outside of a research setting AUSTIN,...
by Chris Barrett | Mar 11, 2022 | Press Releases
Journal of the American College of Obstetricians and Gynecologists (ACOG) publishes randomized controlled superiority trial showing leva’s efficacy in treating UI vs. performing Kegels alone. BOSTON, March 11, 2022 /PRNewswire/ — Renovia Inc....
by Chris Barrett | Mar 8, 2022 | Press Releases
BOSTON, March 7, 2022 /PRNewswire/ — Renovia Inc. (“Renovia”), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that Capital Women’s Care is recommending the leva® Pelvic Health System...
by Chris Barrett | Jan 14, 2022 | Press Releases
The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Medical Devices of 2022. With the medical device industry advancing at an unprecedented rate, new and exciting developments in robotics, materials science, analytics, and other...
by Chris Barrett | Jan 6, 2022 | Press Releases
Global award for Research and Development recognizes Renovia’s commitment to generating the highest quality data supporting leva as effective treatment for urinary incontinence BOSTON, Jan. 6, 2022 /PRNewswire/ — Renovia Inc. (“Renovia”), a...
